113 related articles for article (PubMed ID: 36872079)
1. Early inflammatory biomarkers and melanoma survival.
Fortes C; Mastroeni S; Zappalà AR; Passarelli F; Ricci F; Abeni D; Michelozzi P
Int J Dermatol; 2023 Jun; 62(6):752-758. PubMed ID: 36872079
[TBL] [Abstract][Full Text] [Related]
2. Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Istituto Dermopatico Dell'Immacolata (IDI-IRCCS), Rome, Italy.
Fortes C; Mastroeni S; Sera F; Concolino F; Abeni D; Melchi F; Forastiere F; Pasquini P
Eur J Cancer Prev; 2006 Apr; 15(2):171-7. PubMed ID: 16523015
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
4. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
5. Absolute and relative differential blood count predicts survival of AJCC stage I-II melanoma patients scheduled for sentinel lymph node biopsy.
Wagner NB; Luttermann F; Gassenmaier M; Forschner A; Leiter U; Garbe C; Eigentler TK
Australas J Dermatol; 2020 Aug; 61(3):e310-e318. PubMed ID: 32050042
[TBL] [Abstract][Full Text] [Related]
6. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of hematological profiles in melanoma patients.
Gandini S; Ferrucci PF; Botteri E; Tosti G; Barberis M; Pala L; Battaglia A; Clerici A; Spadola G; Cocorocchio E; Martinoli C
Int J Cancer; 2016 Oct; 139(7):1618-25. PubMed ID: 27252119
[TBL] [Abstract][Full Text] [Related]
8. Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study.
Wade RG; Robinson AV; Lo MCI; Keeble C; Marples M; Dewar DJ; Moncrieff MDS; Peach H
Ann Surg Oncol; 2018 Oct; 25(11):3341-3349. PubMed ID: 30066226
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients.
Gambichler T; Stang A; Mansour R; Scheel CH; Nick C; Abu Rached N; Becker JC; Susok L
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139570
[TBL] [Abstract][Full Text] [Related]
10. High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma.
Zaragoza J; Caille A; Beneton N; Bens G; Christiann F; Maillard H; Machet L
Br J Dermatol; 2016 Jan; 174(1):146-51. PubMed ID: 26343230
[TBL] [Abstract][Full Text] [Related]
11. Mortality in cutaneous malignant melanoma and its association with Neutrophil-to-Lymphocyte ratio.
Pinto-Paz ME; Cotrina-Concha JM; Benites-Zapata VA
Cancer Treat Res Commun; 2021; 29():100464. PubMed ID: 34598061
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
13. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
14. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
15. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].
Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
17. Development and Initial Validation of Calculated Tumor Area as a Prognostic Tool in Cutaneous Malignant Melanoma.
Saldanha G; Yarrow J; Elsheikh S; O'Riordan M; Uraiby H; Bamford M
JAMA Dermatol; 2019 Aug; 155(8):890-898. PubMed ID: 31241720
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
19. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
20. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]